A randomised, multi ‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol

Journal of the Peripheral Nervous System, EarlyView.

Source: Journal of the Peripheral Nervous System - April 26, 2018 Category: Neurology Authors: David R. Cornblath , Hans ‐Peter Hartung , Hans D. Katzberg , Ingemar S. J. Merkies , Pieter A. van Doorn Source Type: research